11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      HPLC separation of naringin, neohesperidin and their C-2 epimers in commercial samples and herbal medicines.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Flavanone glycosides, such as naringin and neohesperidin, are distributed in some Citrus species and have a chiral center in the C-2 position of the flavanone moiety. Naringin and neohesperidin (2S-form) were separated from the corresponding C-2 epimers (2R-epi-form) by normal-phase HPLC using a polysaccaride-derived chiral stationary phases (CSPs), CHIRALPAK IB. The analyses of commercial samples of naringin revealed that the relative ratios of naringin to the C-2 epimer were 29-89%. In the case of a commercial sample of neohesperidin, the relative ratio of the neohesperidin (2S-form) is 84%. The HPLC application to Citrus species used as crude drugs in Japan (Kijitsu, Kikoku and Tohi) showed that the relative ratios of naringin to the C-2 epimer were 75-93% in Kijitsu, 74-79% in Kikoku and 54-64% in Tohi. However, there is a quite small ratio of the (2R)-epi-neohesperidin in Citrus. This result suggested that the averages of relative ratio of (2S)-naringin in Citrus species reduced according to the maturity of fruits (Kijitsu<Kikoku<Tohi). Since the relative ratios of (2S)-naringin of dry extracts of 5 Kampo formulations (including Kijitsu or Kikoku) decreased to 42-54%, the conversion from naringin to the (2R)-epimer might be enhanced during the decoction process of the formulations.

          Related collections

          Author and article information

          Journal
          J Pharm Biomed Anal
          Journal of pharmaceutical and biomedical analysis
          Elsevier BV
          0731-7085
          0731-7085
          Apr 14 2008
          : 46
          : 5
          Affiliations
          [1 ] National Institute of Health Sciences, Tokyo 158-8501, Japan.
          Article
          S0731-7085(07)00227-0
          10.1016/j.jpba.2007.04.004
          17532169
          197cb456-d1cc-4b53-99a9-1f96deaa8591
          History

          Comments

          Comment on this article